COMBINATION CHEMOTHERAPY OF ARA-C-RESISTANT LEUKEMIA-P388 (P388 ARA-C) WITH INHIBITORS OF PURINE AND PYRIMIDINE BIOSYNTHESIS

被引：0
|
作者：
TRADER, MW [1 ]
SCHABEL, FM [1 ]
LASTER, WR [1 ]
BROCKMAN, RW [1 ]
机构：
[1] SOUTHERN RES INST,BIRMINGHAM,AL 35255
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1983年 / 24卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：265 / 265
页数：1
相关论文
共 50 条
  • [1] COLLATERAL SENSITIVITY (CS) OF ARA-C-RESISTANT LEUKEMIA-P388 (P388/ARA-C) TO INHIBITORS OF PURINE BIOSYNTHESIS (IPUB) AND OR PYRIMIDINE BIOSYNTHESIS (IPYB)
    BROCKMAN, RW
    SCHABEL, FM
    LASTER, WR
    TRADER, MW
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 295 - 295
  • [2] THERAPEUTIC SYNERGISM (TS) OF HOMOHARRINGTONINE (H) PLUS 5-FLUOROURACIL (FU) AGAINST LEUKEMIA P388 (P388/0) AND ARA-C-RESISTANT P388 (P388/ARA-C)
    LASTER, WR
    TRADER, MW
    SCHABEL, FM
    CORBETT, TH
    GRISWOLD, DP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 199 - 199
  • [3] COMBINATION CHEMOTHERAPY OF P388/0 AND P388/ARA-C LEUKEMIAS WITH TIAZOFURIN AND SELECTED ANTITUMOR DRUGS
    HARRISON, SD
    TRADER, MW
    LASTER, WR
    GRISWOLD, DP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 323 - 323
  • [4] LEUKEMIA P388-TUMORS RESISTANT TO VINCRISTINE (P388/VCR), ADRIAMYCIN (P388/ADR), OR ARABINOSYLCYTOSINE (P388/ARA-C) - CROSS-RESISTANCE (P388/VCR AND P388/ADR) AND COLLATERAL SENSITIVITY (P388/ARA-C) TO HOMOHARRINGTONINE (H) (NSC 141633)
    WILKOFF, LJ
    DULMADGE, EA
    TRADER, MW
    SCHABEL, FM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 199 - 199
  • [5] THERAPEUTIC SYNERGISM (TS) WITH L-ALANOSINE (A) PLUS N-PHOSPHONACETYL-L-ASPARTATE (PALA) AGAINST ARA-C-RESISTANT LEUKEMIA P388 (P388/ARA-C)
    TRADER, MW
    SCHABEL, FM
    LASTER, WR
    BROCKMAN, RW
    KOVACH, JS
    LIEBER, MM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 187 - 187
  • [6] Effects of naringin on cytosine arabinoside (Ara-C)-induced cytotoxicity and apoptosis in P388 cells
    Kanno, S
    Shouji, A
    Hirata, R
    Asou, K
    Ishikawa, M
    LIFE SCIENCES, 2004, 75 (03) : 353 - 365
  • [7] INCREASE IN ARA-C SENSITIVITY IN ARA-C SENSITIVE AND ARA-C-RESISTANT LEUKEMIA BY STIMULATION OF THE SALVAGE AND INHIBITION OF THE DENOVO PATHWAY
    COLLY, LP
    RICHEL, DJ
    ARENTSENHONDERS, MW
    KESTER, MGD
    TERRIET, PM
    WILLEMZE, R
    ANNALS OF HEMATOLOGY, 1992, 65 (01) : 26 - 32
  • [8] CHARACTERIZATION OF P388 LEUKEMIA RESISTANT TO MITOMYCIN-C (MMC)
    ROSE, WC
    HUFTALEN, JB
    BRADNER, WT
    SCHURIG, JE
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 260 - 260
  • [9] COMBINATION RADIOTHERAPY AND CHEMOTHERAPY FOR P388 LYMPHOCYTIC LEUKEMIA IN-VIVO
    WODINSKY, I
    SWINIARSKI, J
    KENSLER, CJ
    VENDITTI, JM
    CANCER CHEMOTHERAPY REPORTS PART 2 SUPPLEMENT, 1974, 4 (01): : 73 - 97
  • [10] COMBINATION CHEMOTHERAPY WITH ARABINOSYL CYTOSINE (ARA-C) IN ADULT ACUTE LEUKEMIA
    BODEY, GP
    COLTMAN, CA
    FREIREICH, EJ
    CANCER CHEMOTHERAPY REPORTS PART 1, 1973, 57 (01): : 112 - 112
12345